Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryopreservation of autologous mesenchymal stem cells for revision total hip arthroplasty
2016-000926-21Phase 2Completed
- Sponsor
- Fakultní nemocnice Hradec Králové
- Start
- Jun 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous mesenchymal stem cells in hip prosthesis failure and Bone defect, sponsored by Fakultní nemocnice Hradec Králové. Primary endpoint: Safety: incidence of treatment-emergent adverse events. Started Jun 2016; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
hip prosthesis failureBone defect
Beyond the preview
Go deeper on 2016-000926-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000926-21.